Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States.

Breast cancer research and treatment - 1 Aug 2009

Atkinson Charlotte, Newton Katherine M, Aiello Bowles Erin J, Lehman Constance D, Stanczyk Frank Z, Westerlind Kim C, Li Lin, Lampe Johanna W

Abstract excerpt

BACKGROUND: Mammographic breast density is an established marker of breast cancer risk, and is hormonally sensitive. Studies suggest that production of the daidzein metabolites equol and O-Desmethylangolensin (ODMA) may be associated with hormones and hormonally mediated factors, but few studies have assessed relationships between the capacity to produce these metabolites and breast density. OBJECTIVE: To...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gas Chromatography-Mass Spectrometry

Share to Isoflavones

Share to Mammography

Share to Phenotype

Source

Identifiers

PMID: 18821061
DOI: 10.1007/s10549-008-0199-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States.PMID 18821061Read ↗

Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States.Semantic proximity Read ↗

Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.Semantic proximity Read ↗

Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States.Semantic proximity Read ↗

Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States.Semantic proximity Read ↗

Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes.Semantic proximity Read ↗

Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls.Semantic proximity Read ↗

Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes.Semantic proximity Read ↗

Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China.Semantic proximity Read ↗

Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults.Semantic proximity Read ↗

Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women.Semantic proximity Read ↗

Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors.Semantic proximity Read ↗

Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.